 HYDERABAD, India and Princeton, N.J.--BUSINESS WIRE--Dr. Reddys Laboratories Ltd. BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as Dr. Reddys today announced the launch of Icosapent Ethyl Capsules, 1 gram approved by the U.S. Food and Drug Administration USFDA. Dr. Reddys Icosapent Ethyl Capsules, 1 gram is approved for the following indication: as an adjunct to diet to reduce triglyceride TG levels in adult patients with s 